Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  08/12/2019
 
Trade Name:  Dulera Inhalation Aerosol
 
Generic Name or Proper Name (*):  formoterol fumarate/mometasone furoate
 
Indications Studied:  Asthma in pediatric patients 5 -11 years
 
Label Changes Summary:  *Expanded indication to pediatric patients 5 to 11 years; previously approved in pediatric patients 12 years and older. *Safety and effectiveness have not been established in children younger than 5 years. *Safety profile for pediatric patients is similar to that observed in patients aged 12 years and older. *New Dulera 50 mcg/5 mcg metered dose inhaler. *Information on dosing, PK parameters, adverse reactions, lab abnormalities, and clinical trial. *Postmarketing study.
 
BPCA(B) and PREA(P):  B,P
 
Sponsor:  Merck Sharp & Dohme
 
Pediatric Exclusivity Granted Date:  06/24/2019
 
NNPS:  FALSE
 
Therapeutic Category:  Antiasthmatic
 
-
-